|Over a week ago|
Fly Intel: Top five analyst initiations » 09:5402/1702/17/21
PAX, CVET, CHK, HWM, FMTX
Catch up on today's…
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Patria Investments (PAX) initiated with a Buy at Goldman Sachs. 2. Covetrus (CVET) initiated with an Overweight at Barclays. 3. Chesapeake (CHK) initiated with an Overweight at Wells Fargo. 4. Howmet Aerospace (HWM) initiated with an Overweight at KeyBanc. 5. Forma Therapeutics (FMTX) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
Patria Investments initiated with a Buy at Goldman Sachs » 04:5802/1702/17/21
Goldman Sachs analyst…
Goldman Sachs analyst Tito Labarta initiated coverage of Patria Investments with a Buy rating and $28 price target, implying 25% upside. The analyst thinks Patria is well positioned to benefit from the ongoing "equitization" trends in Brazil, given historically low interest rates as investors search for higher yields. Further, the company should benefit from the "relatively underpenetrated" private equity market in Latin America, Labarta tells investors in a research note.
Patria Investments initiated with an Outperform at Keefe Bruyette » 19:4502/1602/16/21
Keefe Bruyette initiated…
Keefe Bruyette initiated coverage of Patria Investments with an Outperform rating and $27 price target.
Patria Investments initiated with an Outperform at Credit Suisse » 06:1502/1602/16/21
Credit Suisse analyst…
Credit Suisse analyst Craig Siegenthaler initiated coverage of Patria Investments with an Outperform rating and $26 price target. The analyst views Patria as the "best-in-class" private markets manager in Brazil/Latin America. He expects significant growth opportunities for the company across private equity, infrastructure, real estate, credit, and listed equities.
Patria initiated with a Neutral at BofA » 06:0502/1602/16/21
BofA initiated coverage…
BofA initiated coverage of Patria with a Neutral rating and $14 price target.
Five new option listings and two option delistings on February 9th » 08:3002/0902/09/21
BCDA, GMTX, GNLN, PAX, PRPH, CLCT, FSDC
New option listings for…
New option listings for February 9th include BioCardia Inc (BCDA), Gemini Therapeutics Inc (GMTX), Greenlane Holdings (GNLN), Patria Investments Ltd (Class A Stock) (PAX), and ProPhase Labs (PRPH). Option delistings effective February 9th include Collectors Universe Inc (CLCT) and FS Development Corporation (Class A Stock) (FSDC).
|Over a month ago|
Opening Day: Mytheresa raises $407M in U.S. market debut » 08:4401/2401/24/21
PAX, MNTK, HUDI, RLX, DFH, MYTE, NAAC, LMACA, LMCA, JCIC, GMII, OSTR, LEGO, RBLX, BMBL, HMPT, COIN, XM, HOMS, PHAR, SAP, NRZ
Mytheresa, which used to…
Patria opens at $21.50, IPO priced at $17 per share 11:5501/2201/22/21
Patria indicated to open at $22, IPO priced at $17 11:2801/2201/22/21
Patria indicated to open at $22.10, IPO priced at $17 » 11:0301/2201/22/21
Patria (PAX) priced…
Patria (PAX) priced 30.099M shares at $17.00, above the $14.00-$16.00 range. JPMorgan, BofA and Credit Suisse acted as joint book running managers for the offering.